New capsule can orally deliver drugs that usually have to be injected
A drug capsule that can carry insulin and protect them from the harsh environment of the gastrointestinal tract has been developed.
List view / Grid view
A drug capsule that can carry insulin and protect them from the harsh environment of the gastrointestinal tract has been developed.
Researchers have developed a series of lipid nanoparticles, which encapsulate RNA, for effective and improved vaccine delivery.
Researchers have developed a chikungunya vaccine that can be stored at warm temperatures and manufactured quickly, which has been validated in animal models.
Health authorities in the Democratic Republic of Congo are planning to use a second vaccine to treat the Ebola virus.
New vaccine patch has showed no negative side effects and could lead to a replacement of needle-based vaccination methods.
Kenya has become the third African country to introduce the world’s first malaria vaccine into the country, in a phased pilot programme.
Janssen’s Brian Woodfall discusses the pharmaceutical company’s research process for their monthly injectable HIV treatment and their predictions for the future of the condition.
The FDA has awarded a breakthrough therapy designation to an investigational prophylactic vaccine to treat respiratory syncytial virus in seniors.
A recent report has predicted that the cervical cancer vaccine market will increase to $6bn by the end of the forecast period.
An investigational Zika vaccine currently being evaluated in a Phase I study has been given a Fast Track designation by the FDA.
A first-of-its-kind experimental chlamydia vaccine trial has been found to be safe and able to provoke an immune response.
A new process developed by the University of Bath protects a TB antigen and a novel vaccine adjuvant from heat damage.
Researchers have detailed recent breakthrough experiments that successfully immunised mice against the Candida auris infection.
The Philippines is considering re-introducing a dengue vaccine whose use was ceased because of links to several deaths.
Rising temperatures will likely accelerate the spread of vector-borne diseases, resulting in an increased demand for vaccines. European Pharmaceutical Review investigates a Morgan Stanley report on the pharmaceutical beneficiaries of climate change.